Among the 43 evaluable patients treated with sevabertinib, the confirmed objective response rate was 72.1%.

Certain air pollutants were associated with changes in metabolites among postmenopausal women in the US, potentially impacting bone health.

Colorado has reported 11 cases, including one 3-case outbreak, in relation to the 1088-case nationwide spread of measles in 2025.

Vaping persistence rates were lower in adolescents who used oral nicotine products including nicotine pouches.

Pediatric community-acquired pneumonia severity can be predicted accurately with 7 factors based on a new model.

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.

Pediatric patients exhibited high risk for severe avian influenza A/H5N1, suggesting clinical therapeutic and vaccine trials should be prioritized in this population.

The FDA has approved Nucala (mepolizumab) for the add-on maintenance treatment of patients with inadequately controlled eosinophilic COPD.

The HHS terminated funding for for Moderna's avian influenza vaccine due to safety concerns with mRNA vaccines.

In PAH, 5-year mortality is similar with and without obesity, even though patients with obesity have more comorbidities and worse functional capacity.

Maternal vaccination and, to a lesser extent, nirsevimab appear to significantly reduce RSV-related hospitalizations in infants.

COVID-19 vaccination during pregnancy was not associated with spontaneous abortion, regardless of dose number or manufacturer.